Molecular basis of nuclear pore formation
Active Grant Awarded
- Award ID
- R01GM166538
- Recipient
-
Sanford Burnham Prebys Medical Discovery Institute UEI PHMKYKKJLQS1
- Awarding agency
-
National Institute of General Medical Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,903,176
Award facts
- Assistance listing
- 93.859 Biomedical Research and Research Training
- Completion date 6% complete
- Place of performance
- La Jolla, CA 92037, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services' National Institutes of Health, through the National Institute of General Medical Sciences, awarded Sanford Burnham Prebys Medical Discovery Institute, doing business as Sanford-Burnham Medical Research Institute, $2.903176 million in obligated funds under Grant R01GM166538 on August 19, 2026. The award falls under Assistance Listing 93.859, Biomedical Research and Research Training.
The grant funds research to define regulatory principles of nuclear pore complex (NPC) biogenesis in mammalian cells, a process linked to cellular aging, neurodegenerative disease, and cancer. Aim 1 determines how ceramides promote NPC formation through membrane bending, microdomain formation, and nucleoporin recruitment. Aim 2 examines how SRSF3-mediated splicing of NUP98/NUP96 transcripts regulates NPC assembly, and it investigates a splicing mechanism that determines whether NUP98 localizes to the NPC or associates with the genome. The proposal builds on a whole-genome siRNA screen that identified ceramide-producing enzymes and the splicing factor SRSF3 as critical for NPC formation.
Performance is in La Jolla, California 92037, with an ultimate completion date of August 31, 2030.
Description
- Abstract
- Nuclear pore complexes (NPCS) are essential protein assemblies that control selective transport between the nucleus and cytoplasm, acting as guardians of the genome. NPC assembly and composition are precisely regulated, and alterations in NPC number and integrity are associated with cellular aging and several human disorders, including neurodegenerative diseases such as alzheimer's (ad) and amyotrophic lateral sclerosis (ALS), premature aging, and cancer. Despite the critical importance of nuclear pores for maintaining cellular homeostasis and their connections to disease, the molecular mechanisms that regulate NPC biogenesis in mammalian cells remain poorly understood. To address this GAP, we recently conducted a whole-genome sirna screen to systematically identify factors that control NPC assembly. This unbiased approach revealed unexpected roles for two pathways: lipid metabolism and RNA splicing. Specifically, we discovered that enzymes regulating ceramide production and the splicing factor SRSF3 are critical for NPC formation. Our preliminary studies suggest that ceramides may act during the early steps of NPC biogenesis by altering nuclear membrane organization and promoting nucleoporin recruitment, while SRSF3 controls the splicing of the NUP98/NUP96 transcript, producing isoforms with distinct roles in NPC assembly and intranuclear genome regulation. Building on these discoveries, this proposal seeks to define new regulatory principles of NPC biogenesis. In aim 1, we will determine how ceramides promote NPC formation, focusing on their roles in membrane bending, microdomain formation, and nucleoporin recruitment. In aim 2, we will dissect how SRSF3-mediated splicing of nucleoporin transcripts, particularly NUP98/NUP96, regulates NPC assembly. As part of this aim, we will also investigate a novel splicing mechanism determining NUP98 localization to NPC or association with the genome, which represents a previously unrecognized mode of nucleoporin function regulation. By integrating lipid biology, RNA splicing, and nuclear pore assembly assays, this research will uncover new regulatory mechanisms of NPC biogenesis. Beyond advancing our fundamental understanding of NPC formation, this work has important translational implications. Dysregulated ceramide metabolism is a well-established feature of ad pathology and progression and known a driver of neurodegeneration, which are linked to loss of NPC function, while SRSF3 is frequently upregulated in cancer, where NPC numbers are increased. These two factors, which we identified as regulators of NPC assembly, are thus already linked to the very diseases most closely associated with pore dysfunction. By establishing ceramides and SRSF3 as central regulators of NPC assembly, this project could expose new therapeutic opportunities for these diseases and other pathologies driven by nuclear transport alterations.
Quick answers
Who received award R01GM166538?
R01GM166538 was awarded to Sanford Burnham Prebys Medical Discovery Institute by National Institute of General Medical Sciences (National Institutes of Health) on August 19, 2026.
How much is award R01GM166538 worth?
$2,903,176 has been obligated on R01GM166538.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award